CS167530B1 - Method of insoluble biologically active compounds preparation - Google Patents

Method of insoluble biologically active compounds preparation

Info

Publication number
CS167530B1
CS167530B1 CS722106A CS210672A CS167530B1 CS 167530 B1 CS167530 B1 CS 167530B1 CS 722106 A CS722106 A CS 722106A CS 210672 A CS210672 A CS 210672A CS 167530 B1 CS167530 B1 CS 167530B1
Authority
CS
Czechoslovakia
Prior art keywords
biologically active
active compounds
compounds preparation
insoluble biologically
insoluble
Prior art date
Application number
CS722106A
Other languages
Czech (cs)
English (en)
Inventor
Jiri Coupek
Jaroslava Turkova
Olga Hubalkova
Miroslava Krivakova
Original Assignee
Jiri Coupek
Jaroslava Turkova
Olga Hubalkova
Miroslava Krivakova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiri Coupek, Jaroslava Turkova, Olga Hubalkova, Miroslava Krivakova filed Critical Jiri Coupek
Priority to CS722106A priority Critical patent/CS167530B1/cs
Priority to CH417873A priority patent/CH577524A5/xx
Priority to GB1399673A priority patent/GB1429534A/en
Priority to NL7304275A priority patent/NL7304275A/xx
Priority to SE7304377A priority patent/SE411905B/xx
Priority to FR7311054A priority patent/FR2178085B1/fr
Priority to CA167,382A priority patent/CA999820A/en
Priority to DE2315508A priority patent/DE2315508A1/de
Priority to AT278873A priority patent/AT336180B/de
Priority to BE129422A priority patent/BE797512A/xx
Priority to JP3514973A priority patent/JPS5738236B2/ja
Publication of CS167530B1 publication Critical patent/CS167530B1/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • C12N11/087—Acrylic polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
    • C12N11/082—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2800/00—Copolymer characterised by the proportions of the comonomers expressed
    • C08F2800/20—Copolymer characterised by the proportions of the comonomers expressed as weight or mass percentages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
CS722106A 1972-03-29 1972-03-29 Method of insoluble biologically active compounds preparation CS167530B1 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
CS722106A CS167530B1 (en) 1972-03-29 1972-03-29 Method of insoluble biologically active compounds preparation
CH417873A CH577524A5 (enrdf_load_stackoverflow) 1972-03-29 1973-03-22
GB1399673A GB1429534A (en) 1972-03-29 1973-03-22 Method for preparation of insoluble biologically active materials
NL7304275A NL7304275A (enrdf_load_stackoverflow) 1972-03-29 1973-03-27
SE7304377A SE411905B (sv) 1972-03-29 1973-03-28 Sett att framstella olosliga biologiskt aktiva material genom bindning av en loslig biologiskt aktiv forening innehallande en aminogrupp till en polymer berare, baserad pa en hydroxyl- eller aminogruppsinnehallande ...
FR7311054A FR2178085B1 (enrdf_load_stackoverflow) 1972-03-29 1973-03-28
CA167,382A CA999820A (en) 1972-03-29 1973-03-28 Method for preparation of insoluble biologically active materials
DE2315508A DE2315508A1 (de) 1972-03-29 1973-03-28 Mit polymeren traegerverbindungen zu unloeslichen materialien vereinigte biologisch aktive stoffe und verfahren zur herstellung derselben
AT278873A AT336180B (de) 1972-03-29 1973-03-29 Verfahren zur herstellung von biologisch aktiven stoffen
BE129422A BE797512A (fr) 1972-03-29 1973-03-29 Procede pour la preparation des matieres biologiquement activites
JP3514973A JPS5738236B2 (enrdf_load_stackoverflow) 1972-03-29 1973-03-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS722106A CS167530B1 (en) 1972-03-29 1972-03-29 Method of insoluble biologically active compounds preparation

Publications (1)

Publication Number Publication Date
CS167530B1 true CS167530B1 (en) 1976-04-29

Family

ID=5357203

Family Applications (1)

Application Number Title Priority Date Filing Date
CS722106A CS167530B1 (en) 1972-03-29 1972-03-29 Method of insoluble biologically active compounds preparation

Country Status (11)

Country Link
JP (1) JPS5738236B2 (enrdf_load_stackoverflow)
AT (1) AT336180B (enrdf_load_stackoverflow)
BE (1) BE797512A (enrdf_load_stackoverflow)
CA (1) CA999820A (enrdf_load_stackoverflow)
CH (1) CH577524A5 (enrdf_load_stackoverflow)
CS (1) CS167530B1 (enrdf_load_stackoverflow)
DE (1) DE2315508A1 (enrdf_load_stackoverflow)
FR (1) FR2178085B1 (enrdf_load_stackoverflow)
GB (1) GB1429534A (enrdf_load_stackoverflow)
NL (1) NL7304275A (enrdf_load_stackoverflow)
SE (1) SE411905B (enrdf_load_stackoverflow)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2621974A1 (de) * 1976-05-18 1977-11-24 Max Planck Gesellschaft Verfahren zur herstellung eines zur kovalenten bindung mit biologisch aktivem material befaehigten traegermaterials
JPS5836624B2 (ja) * 1978-04-05 1983-08-10 旭化成株式会社 血液処理用吸着剤
KR880001097B1 (ko) * 1982-08-12 1988-06-29 다이아몬드 샴락크 코오포레이션 생체선택성 중합체(Biospecific Polymer)
US4737544A (en) * 1982-08-12 1988-04-12 Biospecific Technologies, Inc. Biospecific polymers
DE3381105D1 (de) * 1982-08-12 1990-02-22 Kanegafuchi Chemical Ind Aktivierung biovertraeglicher terpolymere mit biologischen stoffen, deren anzubindende komplemente pathologische effektoren sind.
US4530963A (en) * 1982-08-20 1985-07-23 Devoe-Holbein International, N.V. Insoluble chelating compositions
HU186566B (en) * 1982-08-24 1985-08-28 Reanal Finomvegyszergyar Process for immobilisation of combinations consisting nucleofil group
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
US4685900A (en) * 1983-06-01 1987-08-11 Biospecific Technologies, Inc. Therapeutic device
JPH0644927B2 (ja) * 1987-03-14 1994-06-15 日本油脂株式会社 徐放性活性成分放出剤
CS277464B6 (en) * 1989-09-26 1993-03-17 Ustav Makromolekularni Chemie Contact lens made of hydrophilic gels

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1603393A (enrdf_load_stackoverflow) * 1967-12-27 1971-04-13

Also Published As

Publication number Publication date
CA999820A (en) 1976-11-16
CH577524A5 (enrdf_load_stackoverflow) 1976-07-15
DE2315508C2 (enrdf_load_stackoverflow) 1987-07-16
JPS5738236B2 (enrdf_load_stackoverflow) 1982-08-14
ATA278873A (de) 1976-08-15
FR2178085A1 (enrdf_load_stackoverflow) 1973-11-09
DE2315508A1 (de) 1973-10-18
NL7304275A (enrdf_load_stackoverflow) 1973-10-02
GB1429534A (en) 1976-03-24
FR2178085B1 (enrdf_load_stackoverflow) 1977-04-29
AT336180B (de) 1977-04-25
BE797512A (fr) 1973-07-16
JPS4913385A (enrdf_load_stackoverflow) 1974-02-05
SE411905B (sv) 1980-02-11

Similar Documents

Publication Publication Date Title
ZA731853B (en) Biologically active compounds
ZA766942B (en) Water insoluble biologically active compounds and process for their manufacture
CS167530B1 (en) Method of insoluble biologically active compounds preparation
ZA727850B (en) Biologically active substance
ZA733016B (en) Preparation of thiocarbamylsulfenamides
ZA72698B (en) Method of preparing medicinal compositions
IL43491A (en) Preparation of phosponothioureido compounds
IL42108A0 (en) The preparation of biologically active polypeptides containing aspartyl group
IL43318A0 (en) Novel 13-bromo-lysergic acid compounds and their preparation
BG24662A3 (en) Method of preparing d-1-11-15-dideoxoprostagland ne-e1
ZA73142B (en) Preparation of 2-alkoxy-5-alkylsulphonyl-benzoic acids
ZA732920B (en) Manufacture of tetramisole
CS181238B2 (en) Method of preparing 2-benzoyl-3-aminopyridines
KR780000255B1 (en) Preparation method of n-(diethalaminoethal)-2-methoxy-5-methylsulphonyl-benzamide
ZA7332B (en) Biologically active di-aryl compounds
BG24663A3 (en) Method of preparing succinylsuccinic acid dieste s
IL42055A (en) Preparation of 2-chloroethanephosphonic acid
ZA728858B (en) Biologically active substance
EG11435A (en) Process for preparation of n(1-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-ethylsulphonyl-benzamide
ZA738505B (en) Biologically active compounds
ZA732580B (en) Method of contraception by the administration of stage-combination preparation
ZM6573A1 (en) Process of providing active surfaces
ZA72169B (en) Biologically active substance
IL42457A (en) Method of preparing 2-alkoxy-5-alkylsulfonyl-benzoic acid
ZA735210B (en) Biologically active compounds and compositions